FCGRT and myasthenia gravis: Other FcRn inhibitors like Batoclimab are also in clinical trials, including a phase III trial for generalized MG (ClinicalTrials.gov Identifier: NCT05403541) and testing in patients with active CIDP (ClinicalTrials.gov Identifier: NCT05581199).